Market revenue in 2024 | USD 16.9 million |
Market revenue in 2030 | USD 26.9 million |
Growth rate | 8.1% (CAGR from 2025 to 2030) |
Largest segment | Immunoproteins |
Fastest growing segment | Microbial and Infectious Disease |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Routine and Special Chemistry, Flow Cytometry, Hematology, Immunoproteins, Microbial and Infectious Disease, Coagulation Testing |
Key market players worldwide | Abbott Laboratories, Danaher Corp, Roche Holding AG ADR, BD, EKF Diagnostics Holdings PLC, BioMerieux SA, Siemens Healthineers AG ADR, Bayer AG, Chembio Diagnostic Systems Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to critical care diagnostics market will help companies and investors design strategic landscapes.
Immunoproteins was the largest segment with a revenue share of 39.05% in 2024. Horizon Databook has segmented the Australia critical care diagnostics market based on routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious disease, coagulation testing covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia critical care diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia critical care diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account